CVS Health (CVS) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health Reports Third Quarter Results
November 6, 2018 6:55 AM ESTWOONSOCKET, R.I., Nov. 6, 2018 /PRNewswire/ --
Third Quarter Year-over-Year Highlights:
Net revenues increased 2.4% to $47.3 billion Same store prescription volume growth of 9.2% Pharmacy Services claims growth of 5.7% GAAP diluted EPS from continuing operations of $1.36 Adjusted EPS of $1.73Year-to-date Highlights:
Generated cash flow from operations of $6.4 billion; free cash flow of $4.9 billionFull Year Guidance:
GAAP operating profit decline of 39% to 41%, reflecting goodwill impairment in Q2 Adjusted operating profit change of... More